DOCSLIB.ORG

Department of Health Regulations: Impact on Business

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Department of Health Regulations: Impact on Business An Audit of the impact of the Department of Health’s Regulations upon business Final Report September 2013 1 Contents Executive summary .................................................................................................................. 4 Background .............................................................................................................................. 6 DH Regulatory landscape ......................................................................................................... 7 Audit Results .......................................................................................................................... 10 Annex A - Detailed commentary on the Department of Health’s stock of regulations ............. 12 1. Care Quality .................................................................................................................... 13 1.1 Care Quality Commission (CQC) .................................................................................. 13 1.2 Mental Health and Mental Capacity .............................................................................. 18 1.3 Social Care (Isles of Scilly) ........................................................................................... 23 1.4 Social Care other .......................................................................................................... 24 2. Medicines and Healthcare products Regulatory Agency (MHRA) ................................... 25 2.1 Blood ............................................................................................................................. 26 2.2 Clinical Trials................................................................................................................. 28 2.3 Devices ......................................................................................................................... 30 2.4 Fees .............................................................................................................................. 33 2.5 Good Laboratory Practice ............................................................................................. 36 2.6 Herbals ......................................................................................................................... 37 2.7 Homeopathics ............................................................................................................... 39 2.8 Pharmaceuticals ........................................................................................................... 41 2.9 Transmissible Spongiform Encephalopathies (TSEs) ................................................... 46 3. Medicines, Pharmacy, Dental and Ophthalmic Services ................................................. 48 3.1 Charges and benefits .................................................................................................... 50 3.2 Dental ........................................................................................................................... 52 3.3 General Pharmaceutical Services, Local Pharmaceutical Services, Controlled Drugs, Responsible Pharmacist and non-medical prescribing ....................................................... 54 3.4 Ophthalmic Services ..................................................................................................... 59 4. NHS ................................................................................................................................. 63 4.1 Cost recovery ................................................................................................................ 63 4.2 NHS Litigation ............................................................................................................... 67 5. Public Health ................................................................................................................... 70 5.1 Abortion ........................................................................................................................ 70 5.2 Blood and tissue ........................................................................................................... 73 5.3 Food composition, labelling and safety ......................................................................... 76 5.4 Healthy Start and Welfare Food .................................................................................... 78 2 An Audit of the impact of the Department of Health’s Regulations upon business 5.5 Health Protection .......................................................................................................... 81 5.6 Health Protection – Port Health and Travel ................................................................... 84 5.7 Health Protection – Vaccinations .................................................................................. 86 5.8 Human Fertilisation and Embryology Authority (HFEA) ................................................ 87 5.9 HIV / Venereal Disease ................................................................................................. 90 5.10 National Child Measurement Programme (NCMP) ..................................................... 92 5.11 Radiation ..................................................................................................................... 93 5.12 Surrogacy ................................................................................................................... 96 5.13 Tobacco ...................................................................................................................... 97 5.14 Other ......................................................................................................................... 103 6. Professional Standards ................................................................................................. 105 Annex B – Professional Standards additional information .................................................... 109 List of Registered Professions .......................................................................................... 109 Full List of Professional Standards Regulations ................................................................ 110 Annex C - Research Approach ............................................................................................. 116 Overview ........................................................................................................................... 116 Research Stages .............................................................................................................. 116 Estimating costs and benefits ........................................................................................... 117 Reliability rating ................................................................................................................ 119 Annex D – NHS regulations thought to have no impact to business .................................... 120 Annex E - the Department of Health’s closing position on Statement of New Regulation Five ............................................................................................................................................. 124 Annex F – Full tables of regulations in and out of scope and potential to revoke by policy area ............................................................................................................................................. 126 Annex G – Tobacco Control Additional information on costs and benefits ........................... 132 Annex H – Deregulatory measures ...................................................................................... 136 3 Executive summary 1. The purpose of this Audit report is to provide a thorough overview of all the regulations for which DH has responsibility that are thought to have an impact to business. The Audit describes why we have the regulations, provides an assessment of their estimated costs and, where possible, benefits to business and to wider society. The Audit has been conducted with a view to identifying regulations that should be removed or consolidated to reduce the regulatory burden the Department places on business and Civil Society Organisations (hereafter “business”) as well as reducing the number and scope of our regulations. 2. The scope of the Audit covered all regulations believed to have a potential cost to business. In a Cabinet Office trawl for the Red Tape Challenge (RTC) around 1,200 regulations had been identified as the responsibility of the Department of Health, a significant subset of which was put forward for review under the RTC. Many of the regulations attributed to the Department of Health (DH) clearly only impact on the public sector or are in fact owned by Other Government Departments. These were excluded from the scope of the Audit which has focussed on just over 650 individual regulations (Statutory Instruments for the most part). 3. There are differences between the set of regulations considered in this Audit and the set examined in the Red Tape Challenge phases one (Medicines) and two (Healthy Living and Social Care) which together cover 774 regulations. This is because this Audit did not include some regulations revoked shortly after RTC phase one (214 MHRA regulations) and because we included 91 additional regulations identified by policy teams outside of these RTC processes. The derivation of the set of regulations included in scope of the Audit is set out in the annex on the Research approach (Annex C). 4.
Load more

Recommended publications
  • Legal and Regulatory Approaches to Rehabilitation Planning
    International Journal of Environmental Research and Public Health Review Legal and Regulatory Approaches to Rehabilitation Planning: A Concise Overview of Current Laws and Policies Addressing Access to Rehabilitation in Five European Countries Aditi Garg 1,*, Dimitrios Skempes 1,2 and Jerome Bickenbach 1,2 1 Department of Health Sciences and Medicine, University of Lucerne, Frohburgstrasse 3, 6002 Luzern, Switzerland; [email protected] (D.S.); [email protected] (J.B.) 2 Swiss Paraplegic Research, Guido A. Zäch Str. 4, 6207 Nottwil, Switzerland * Correspondence: [email protected]; Tel.: +1-519-239-5295 Received: 6 May 2020; Accepted: 5 June 2020; Published: 18 June 2020 Abstract: Background: The rising prevalence of disability due to noncommunicable diseases and the aging process in tandem with under-prioritization and underdevelopment of rehabilitation services remains a significant concern for European public health. Over recent years, health system responses to population health needs, including rehabilitation needs, have been increasingly acknowledging the power of law and formal written policies as strategic governance tools to improve population health outcomes. However, the contents and scope of enacted legislation and adopted policies concerning rehabilitation services in Europe has not been synthesized. This paper presents a concise overview of laws and policies addressing rehabilitation in five European countries. Methods: Publicly available laws, policies, and national action plans addressing rehabilitation issues of Sweden, Italy, Germany, the Netherlands and the United Kingdom were reviewed and descriptive documents analyzed. Actions found in national health policies were also evaluated for compliance with the key recommendations specified in the World Health Organization’s Rehabilitation 2030: Call for Action.
    [Show full text]
  • Health Service Commissioners Act 1993
    Changes to legislation: There are outstanding changes not yet made by the legislation.gov.uk editorial team to Health Service Commissioners Act 1993. Any changes that have already been made by the team appear in the content and are referenced with annotations. (See end of Document for details) ELIZABETH II c. 46 Health Service Commissioners Act 1993 1993 CHAPTER 46 An Act to consolidate the enactments relating to the Health Service Commissioners for England, for Wales and for Scotland with amendments to give effect to recommendations of the Law Commission and the Scottish Law Commission. [5th November 1993] F1Be it enacted by the Queen’s most Excellent Majesty, by and with the advice and consent of the Lords Spiritual and Temporal, and Commons, in this present Parliament assembled, and by the authority of the same, as follows:— Annotations: Amendments (Textual) F1 Act repealed (S.) (23.10.2002) by 2002 asp 11, s. 25(1), Sch. 6 para. 14 (with savings in Sch. 7); S.S.I. 2002/467, art. 2 Modifications etc. (not altering text) C1 Act applied (1.4.1999) by S.I. 1999/686, art. 5(1), Sch. Pt. II Act applied (with modifications)(1.4.1999) by S.I. 1999/726, art. 5(1)(2), Sch. Pt. II Act applied (6.4.2001) by S.I. 2001/137, art. 5, Sch. Pt. II Act applied (S.) (31.3.2002) by S.S.I. 2002/103, art. 6, Sch. Pt. II (with art. 4(4)) Act applied (S.) (27.6.2002) by S.S.I. 2002/305, art.
    [Show full text]
  • Part I Background and Summary
    PART I BACKGROUND AND SUMMARY Chapter 1 BRITISH STATUTES IN IDSTORICAL PERSPECTIVE The North American plantations were not the earliest over­ seas possessions of the English Crown; neither were they the first to be treated as separate political entities, distinct from the realm of England. From the time of the Conquest onward, the King of England held -- though not necessarily simultaneously or continuously - a variety of non-English possessions includ­ ing Normandy, Anjou, the Channel Islands, Wales, Jamaica, Scotland, the Carolinas, New-York, the Barbadoes. These hold­ ings were not a part of the Kingdom of England but were govern­ ed by the King of England. During the early medieval period the King would issue such orders for each part of his realm as he saw fit. Even as he tended to confer more and more with the officers of the royal household and with the great lords of England - the group which eventually evolved into the Council out of which came Parliament - with reference to matters re­ lating to England, he did likewise with matters relating to his non-English possessions.1 Each part of the King's realm had its own peculiar laws and customs, as did the several counties of England. The middle ages thrived on diversity and while the King's writ was acknowledged eventually to run throughout England, there was little effort to eliminate such local practices as did not impinge upon the power of the Crown. The same was true for the non-Eng­ lish lands. An order for one jurisdictional entity typically was limited to that entity alone; uniformity among the several parts of the King's realm was not considered sufficiently important to overturn existing laws and customs.
    [Show full text]
  • Biodefense and Constitutional Constraints
    Georgetown University Law Center Scholarship @ GEORGETOWN LAW 2011 Biodefense and Constitutional Constraints Laura K. Donohue Georgetown University Law Center, [email protected] Georgetown Public Law and Legal Theory Research Paper No. 11-96 This paper can be downloaded free of charge from: https://scholarship.law.georgetown.edu/facpub/677 http://ssrn.com/abstract=1882506 4 Nat'l Security & Armed Conflict L. Rev. 82-206 (2014) This open-access article is brought to you by the Georgetown Law Library. Posted with permission of the author. Follow this and additional works at: https://scholarship.law.georgetown.edu/facpub Part of the Constitutional Law Commons, and the Military, War, and Peace Commons BIODEFENSE AND CONSTITUTIONAL CONSTRAINTS Laura K. Donohue* I. INTRODUCTION"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" & II. STATE POLICE POWERS AND THE FEDERALIZATION OF U.S. QUARANTINE LAW """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" 2 A. Early Colonial Quarantine Provisions""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" 3 """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" 4 """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""&)
    [Show full text]
  • How Can the Lens of Human Rights Provide a New Perspective on Drug Control and Point to Different Ways of Regulating Drug Consumption?
    How can the lens of human rights provide a new perspective on drug control and point to different ways of regulating drug consumption? A thesis submitted to The University of Manchester for the degree of Doctor of Philosophy in the Faculty of Humanities 2015 Melissa L. Bone School of Law Table of Contents Index of Tables……………………………………………………………………..….5 Table of Cases………………………………………….………………………………6 Table of Statutes, Treaties and Legislative Instruments……………………………....10 List of Abbreviations…………………………………………………………………15 Abstract………………………………………………...…………………………….18 Candidate’s Declaration and Copyright Statement…………………………………...19 Acknowledgements…………………………………...……………………………...20 Introduction………………………………………………………………..…………22 Chapter 1: Understanding the origin and value of human rights and psychoactive consumption………………………………………………………………………….32 1.1 What are human rights and where have they come from?………..……………….33 1.2 Human right foundations and the question of importance…………...……………36 1.3 The grounds for human rights…………………………………………….………42 1.3.1 ‘The universalist challenge’…………………………………………..46 1.4 The origin and value of human psychoactive consumption……………………….49 1.5 Conclusion……………………………………………………………..…………54 Chapter 2: Understanding how human rights can address the drug policy binary: the conflict between the interests of the State and the interests of the individual………….55 2.1 Defining ‘the State’……………………………………………………...………..56 2.2 Identifying four ‘typical philosophical positions and the binary which underpins them……………………………………………………………….………………….62
    [Show full text]
  • Key Dates in Tobacco Regulation 1962 — 2020
    Key dates in tobacco regulation 1962 — 2020 16 Further information about the early history of tobacco is available at: www.tobacco.org/History/history.html 1962 The first Royal College of Physicians (RCP) report, "Smoking and Health", was published. It received massive publicity. The main recommendations were: restriction of tobacco advertising; increased taxation on cigarettes; more restrictions on the sales of cigarettes to children, and smoking in public places; and more information on the tar/nicotine content of cigarettes. For the first time in a decade, cigarette sales fell. The Tobacco Advisory Committee (subsequently Council, and now known as the Tobacco Manufacturers’ Association) - which represents the interests of the tobacco industry - agreed to implement a code of advertising practice for cigarettes which was intended to take some of the glamour out of cigarette advertisements. The code was based on the former ITA code governing cigarette advertisements on TV (before they were removed in 1964, with the co-operation of the ITA) 1964 The US Surgeon General produced his first report on "Smoking and Health". Its conclusions corroborated those of the RCP and the US Surgeon General has produced annual reports since 1967 on the health consequences on smoking. Doll and Hill published the results of a nationwide prospective survey on "mortality in relation to smoking: 10 years' observations in British Doctors". Between 1951 and 1964 about half the UK's doctors who smoked gave up and there was a dramatic fall in lung cancer incidence among those who gave up as opposed to those who continued to smoke. 1965 After considerable debate, the government used the powers vested in it under the terms of the 1964 Television Act to ban cigarette advertisements on television.
    [Show full text]
  • National Implementing Measures
    n;J .f~ COMMISSION OF THE EUROPEAN COMMUNITIES National Implementing Measures to give effect to the White Paper of the Commission on the Completion of the Internal Market Situation at 30 April 1991 0 0 () c s:: •*• m * * z * * -1 * * 92 * * * This document has been prepared for use within the Commission. It does not necessarily represent the Commission's official position. Cataloguing data can be found at the end of this publication. Luxembourg: Office for Official Publications of the European Communities, 1991 ISBN 92-826-2694-6 Catalogue number: CM-70-91-782-EN-C © ECSC-EEC-EAEC, Brussels • Luxembourg, 1991 Reproduction is authorized, except for commercial purposes, provided the source is acknowledged. Printed in Belgium NOTE TO READERS This guide, available In all the official languages of the Conunlty, Is beIng pub II shed as part of an I nfor~~at I on exercIse. It was designed as a documentary tool and In no way binds the Conlsslon. The lnforutlon It contains Is drawn from the INF092 data base accessible to the public and there Is no Implied crltlcln or otherwise of what the Member States have done. Measures whIch have not been offIcI a II y notIfIed are not II sted. Because the situation Is constantly changing, the guide can do no more than ref I ect the posIt I on on a gIven date, In thIs case 30 April 1991. A new edition wl I I appear every six months . • • • TABLE OF CONTENTS I. THE REMOVAL OF PHYSICAL BARRIERS Control of goods Dlr. 85/347 Duty-free fuel contained In fuel tanks of commercial 1otor vehicles Reg.
    [Show full text]
  • Sp Catalog B 06
    Scottish Parliamentary and Statutory Publications January 2004 - July 2004 Published 2008 ISBN: 978 033880065 7 TSO subscription classification: 7001039 Contents TSO Contacts iv Business Bulletin 27 Contacts iv What’s happening in the Scottish Parliament 30 Introduction 1 SPICe Research Publications 31 Parliamentary Publications 3 SPICe Briefings 31 Bills 3 IPRN Briefings 31 Scottish Parliament Bills - Session 2 (2004) 3 Documents Subject to Scrutiny 33 Passage of Bills 7 Laid Papers 33 Parliamentary Papers 7 Scottish Executive Papers 2003 33 Scottish Parliament papers - Session 2 (2004) 8 Scottish Executive Papers 2004 34 Official Report - Plenary Session 14 Auditor General for Scotland 38 Scottish Public Services Ombudsman 38 Official Report - Plenary Session 14 Scottish Parliamentary Standards Commissioner 38 Minutes of Proceedings 15 Draft Statutory Instruments 38 Written Answers Report 17 Petitions 40 Official Report (Committees) 18 Audit Committee 18 Statutory Publications 45 Communities Committee 18 Acts 45 Edinburgh Tram (Line Two) Bill Committee 19 Education Committee 19 Acts of the Scottish Parliament 2004 45 Enterprise and Culture Committee 20 Acts of the Scottish Parliament - Environment and Rural Development Committee 20 Explanatory notes 2004 46 Equal Opportunities Committee 21 Statutory Instruments 47 European and External Relations Committee 21 Finance Committee 22 Commencement orders 2003 47 Health Committee 22 Commencement orders 2004 47 Justice 1 and Justice 2 Committees 23 Scottish statutory instruments 2003 48 Justice
    [Show full text]
  • Health and Care Bill Explanatory Notes
    HEALTH AND CARE BILL EXPLANATORY NOTES What these notes do These Explanatory Notes relate to the Health and Care Bill as introduced in the House of Commons on 6 July 2021 (Bill 140). • These Explanatory Notes have been prepared by the Department of Health and Social Care in order to assist the reader of the Health and Care Bill and to help inform debate on it. They do not form part of the Health and Care Bill and have not been endorsed by Parliament. • These Explanatory Notes explain what each part of the Health and Care Bill will mean in practice; provide background information on the development of policy; and provide additional information on how the Health and Care Bill will affect existing legislation in this area. • These Explanatory Notes might best be read alongside the Health and Care Bill. They are not, and are not intended to be, a comprehensive description of the Health and Care Bill. Bill 140–EN 58/2 Table of Contents Subject Page of these Notes Overview of the Health and Care Bill 10 Policy Background 11 Merging NHS England, Monitor and NHS Trust Development Authority 11 Mandate and financial directions to NHS England 12 Funding for service integration 14 The NHS Payment Scheme 14 Capital spending limits over Foundation Trusts 15 New NHS Trusts 16 Integrated Care Boards and Integrated Care Partnerships 17 Triple Aim 17 Duty to Cooperate 18 Joint Appointments 18 Joint Committees 18 Collaborative Commissioning 18 Secretary of State’s duty to report on workforce systems 19 Abolition of LETBs 20 Information 20 Secretary of State
    [Show full text]
  • The Speech Or Debate Clause: Bastion of Congressional Independence Or Haven for Corruption, 57 N.C
    NORTH CAROLINA LAW REVIEW Volume 57 | Number 2 Article 3 2-1-1979 The pS eech or Debate Clause: Bastion of Congressional Independence Or Haven for Corruption Craig M. Bradley Follow this and additional works at: http://scholarship.law.unc.edu/nclr Part of the Law Commons Recommended Citation Craig M. Bradley, The Speech or Debate Clause: Bastion of Congressional Independence Or Haven for Corruption, 57 N.C. L. Rev. 197 (1979). Available at: http://scholarship.law.unc.edu/nclr/vol57/iss2/3 This Article is brought to you for free and open access by Carolina Law Scholarship Repository. It has been accepted for inclusion in North Carolina Law Review by an authorized administrator of Carolina Law Scholarship Repository. For more information, please contact [email protected]. THE SPEECH OR DEBATE CLAUSE: BASTION OF CONGRESSIONAL INDEPENDENCE OR HIAVEN FOR CORRUPTION? CRAIG M. BRADLEYt As the popular concern gradually shifts away from the problem of a corrupt presidency to the more familiar problem of the corrupt con- gressman, it seems appropriate to reconsider the principles of congres- sional privilege. While the constitutionally guaranteed congressional privileges, such as the freedom of speech or debate, may tend to protect Congress from overreaching by the executive, they may also have the effect of shielding corrupt congressmen from legitimate efforts to inves- tigate and prosecute their transgressions. Indeed, in the investigation of the Korean corruption of the United States Congress the investiga- tive efforts of the Justice Department
    [Show full text]
  • April 2021 International Trade Compliance Update
    International Trade Compliance Update (Covering Customs and Other Import Requirements, Export Controls and Sanc- tions, Trade Remedies, WTO and Anti-Corruption) Newsletter | April 2021 In This Issue: World Trade Organization (WTO) World Customs Organization (WCO) Other International Matters The Americas - North America The Americas - South America Please see our Webinars, Meetings, Seminars section for information for Asia-Pacific links to the webinars in our 18th annual Global Trade and Supply Chain Europe, Middle East and North Africa Webinar Series: “International Trade & Developments in a World Fo- cused on Recovery & Renewal,” which just began, as well as links to addi- Africa (except North Africa) tional webinars and other events. Newsletters, reports, articles, etc. There are also links to the video recordings, PowerPoints and handout materi- Webinars, Meetings, Seminars, etc. als of the WTO Cov id-19 Notifications 2020-2021 Asia Pacific International Commercial and Trade Webi- WTO TBT Notifications nar Series CBP Rulings: Downloads and Searches 2020 Virtual Trade Conference (July 14-16 2020) CBP Rulings: Rev ocations or Modifi- 2020 Virtual Year-End Review of Import/Export Developments cations European Classification Regulations 2020 Global Trade and Supply Chain Webinar Series: Interna- Amendments to the CN Explanatory tional Trade Basics and Trends Notes To keep abreast of international trade-related news, visit our blogs: Section 337 Actions For International Trade Compliance Updates, please regularly visit Antidumping, Counterv ailing Duty https://www.internationaltradecomplianceupdate.com/. and Safeguard Inv estigations, Or- ders & Reviews For additional articles and updates on trade sanctions and export controls, please visit: http://sanctionsnews.bakermckenzie.com/ regularly. For resources and news regarding international trade, particularly in Asia, please visit our Trade Crossroads blog at http://tradeblog.bakermckenzie.com/.
    [Show full text]
  • Monday 5 October Herbert Smith Freehills Exchange House Primrose Street London Ec2a 2Hs 9.30 – 17.30
    MONDAY 5 OCTOBER HERBERT SMITH FREEHILLS EXCHANGE HOUSE PRIMROSE STREET LONDON EC2A 2HS 9.30 – 17.30 EARN 6 CPD POINTS SRA/BSB/ILEX Speakers: DAVID ANDERSON QC, TIM BULEY, JAMIE BURTON, SARAH CLARKE, SIMON CREIGHTON, DEBA DAS, TOM DE LA MARE QC, MARIE DEMETRIOU QC, MICHAEL DRURY CMG, MIKE FORDHAM QC, PROF CONOR GEARTY, RICHARD GORDON QC, JOHN HALFORD, RICHARD HERMER QC, PHILLIPPA KAUFMANN QC, ERIC KING, LORD JUSTICE LAWS, ANDREW LIDBETTER, DAVID LOCK QC, JOANNA LUDLAM, NICOLA MACKINTOSH QC (HONS), RAVI MEHTA, TIM OTTY QC, NAINA PATEL, JASVEER RANDHAWA, JENNI RICHARDS QC, ALICE ROSS, TOM SNELLING, MICHAEL SPENCER, IAIN STEELE, KATE STONE, ADAM STRAW, HUGH TOMLINSON QC, HEATHER WILLIAMS QC Programme: TOP CASES OF THE YEAR, PARLIAMENTARY VANDALISM AND NEW HUMAN RIGHTS, INFORMATION PROCESSING AND DISCLOSUE BY PUBLIC AUTHORITIES, SURVEILLANCE AND THE LAW, THE RELATIONSHIP BETWEEN LITIGATION AND POLICY, HENRY VIII CLAUSES, THE IMPACT OF TERRORISM POLICY ON FREE SPEECH, EU LAW IN DOMESTIC JUDICIAL REVIEW, PROPORTIONALITY - WHAT LIES BENEATH THE LABEL?, VICTIMS, SUSPECTS AND CONVICTS, CHALLENGING NHS DECISIONS, PUBLIC LAW AND THE REGULATORS, INTERNATIONAL LAW IN DOMESTIC COURTS, SOCIAL SECURITY SALAMI SLICING MORNING SESSION PLENARY CHAIR: JENNI RICHARDS QC, 39 ESSEX STREET CHAMBERS 9.00 COFFEE AND REGISTRATION MORNING BREAKOUT SESSIONS Each session is scheduled to last one hour. 9.30 INTRODUCTION FROM THE CHAIR OF Please choose one of the following THE PUBLIC LAW PROJECT 1. EU law in domestic judicial review • Relying on EU law in domestic proceedings 9.35 OPENING ADDRESS: LORD JUSTICE LAWS • Charter: status and horizontal effect • Securing a reference and interveners 10.00 TOP PUBLIC LAW CASES OF THE YEAR: • Practical points for Luxembourg Naina Patel and Iain Steele, Blackstone Chambers & Joanna Ludlam, Partner, Baker McKenzie LLP Deba Das, Senior Associate, Freshfields, Tom Snelling, Partner, Freshfields & Marie Demetriou QC, Brick Court Chambers 10.45 PARLIAMENTARY VANDALISM AND NEW HUMAN RIGHTS 2.
    [Show full text]